These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Mortality due to sepsis in patients with systemic lupus erythematosus and rheumatoid arthritis. Barrett O; Abramovich E; Dreiher J; Novack V; Abu-Shakra M Isr Med Assoc J; 2014 Oct; 16(10):634-5. PubMed ID: 25438453 [No Abstract] [Full Text] [Related]
26. [On the diagnostic value of capsule biopsy in various joint diseases]. Zeitlhofer J Z Rheumaforsch; 1969; 28(3):83-92. PubMed ID: 4894343 [No Abstract] [Full Text] [Related]
27. [Nosologic and diagnostic problems in chronic polyarthritis (P.C.E.)]. Delbarre F Wien Z Inn Med; 1968; 49(5):167-79. PubMed ID: 4187766 [No Abstract] [Full Text] [Related]
28. The relative value of antibody assays in the differential diagnosis of systemic lupus erythematosus and rheumatoid arthritis with special emphasis to ultramicro ELISA for anti-ds DNA. Wollina U Dermatol Monatsschr; 1984; 170(10):645-7. PubMed ID: 6391968 [No Abstract] [Full Text] [Related]
29. [The primary chronic polyarthritis with LE cells, a link to systemic lupus erythematosus]. Geidel H Munch Med Wochenschr; 1967 Dec; 109(48):2534-9. PubMed ID: 4174576 [No Abstract] [Full Text] [Related]
30. A four-year review of systemic lupus erythematosus. Seboxa T; Teklu B; van der Meulen J Ethiop Med J; 1984 Jan; 22(1):13-6. PubMed ID: 6690298 [No Abstract] [Full Text] [Related]
31. Unresponsiveness of C-reactive protein in the non-infectious inflammation of systemic lupus erythematosus is associated with interleukin 6. Suh CH; Chun HY; Ye YM; Park HS Clin Immunol; 2006 Jun; 119(3):291-6. PubMed ID: 16406714 [TBL] [Abstract][Full Text] [Related]
32. ["False positive" LE cell phenomenon]. Bartusch M; Krug K Z Rheumaforsch; 1969; 28(7):298-305. PubMed ID: 4186550 [No Abstract] [Full Text] [Related]
33. The immunofluorescent tumor imprint technique. IV. The significance of "thready" nuclear immunofluorescence. Burnham TK; Neblett TR; Fine G; Bank P Arch Dermatol; 1969 May; 99(5):611-6. PubMed ID: 4889089 [No Abstract] [Full Text] [Related]
35. [Polyneuritis with the biological syndrome of systemic lupus erythematosus]. Volmat R; Allers G; Vittouris N; Bizouard P; Narboni G; Gross M; Lenys R Encephale; 1969; 58(4):336-48. PubMed ID: 5378190 [No Abstract] [Full Text] [Related]
36. [Use of magnetosorbents in the immunodiagnosis and therapy of systemic lupus erythematosus and rheumatoid arthritis]. ZborovskiÄ AB; Gontar' IP Klin Med (Mosk); 2001; 79(2):42-5. PubMed ID: 11419085 [TBL] [Abstract][Full Text] [Related]
37. Serum amyloid P-component levels in rheumatoid arthritis. Levo Y; Ehrenfeld M; Wollner S Isr J Med Sci; 1982 Jun; 18(6):715-7. PubMed ID: 7107210 [No Abstract] [Full Text] [Related]
38. [Diagnostic difficulties and the characteristics of the main symptoms in systemic lupus erythematosus]. Kosicka T; Rybicka K Pol Tyg Lek; 1981 Sep; 36(37):1425-7. PubMed ID: 7335519 [No Abstract] [Full Text] [Related]
39. [Paraspecific manifestations of tuberculosis simulating systemic connective tissue diseases]. Chumakova LP; Khanin AL Klin Med (Mosk); 1983 Dec; 61(12):36-40. PubMed ID: 6668909 [No Abstract] [Full Text] [Related]
40. [Analysis of the acid glycoprotein heterogeneity in patients with arthritis]. Domysławska I; Lewandowski B; Kita K; Klimiuk PA; Sierakowski S Pol Merkur Lekarski; 2004 Oct; 17(100):349-52. PubMed ID: 15690699 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]